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Abstract 
Cells adhere to their extracellular matrix by way of integrins, transmembrane 
molecules that attach the cytoskeleton to the extracellular basement membrane (one kind 
of extracellular matrix). In some muscular dystrophies, specific integrins are disrupted 
and muscle fibers detach from the myotendenous junction and degenerate. This integrin 
disruption causes a constant cycle of regeneration and degeneration, which greatly harms 
the tissue over time. Congenital muscular dystrophy affects the integrin alpha 7 gene and 
prevents the muscle cell from producing the affiliated protein. In an attempt to rescue 
integrin alpha 7 dystrophies, this project over-expressed another integrin, integrin alpha 
6, in zebrafish (Danio rerio). Preliminary data suggest it is possible to prevent fiber 
detachments in muscle, a characteristic of dystrophy, by over-expressing integrin alpha 6 
in zebrafish lacking integrin alpha 7. Furthermore, a limited number of embryos, with 
both integrin alpha 7 and dystroglycan 1 deficiencies, show improved muscle structure 
when over-expressing the integrin alpha 6 protein. The integrin alpha 6 protein may hold 
promise for gene therapy applications because it already exists within the muscle fibers, 
reducing the risk of immunorejection. This protein may serve a useful therapeutic 
purpose if it can be both expressed uniformly and effectively in human skeletal muscle.  
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Introduction 
Cells, within a tissue, do not exist in a vacuum. They are connected to an 
extracellular matrix (ECM) consisting of many types of proteins and fibrous collagen. 
Developmental biology is concerned with determining how cells become different from 
one another and interact with their extracellular microenvironment. A tissue is composed 
of cells that attach to a collagenous basement membrane. The basement membrane 
separates epithelial cells from the underlying mesenchymal tissue and consists of protein 
fibers. This basement membrane is a critical component of the ECM. Cells that make up 
the epithelium of a tissue rely on transmembrane protein complexes to maintain a 
connection with the basement membrane and the underlying supportive tissue. 
Pathologies exist that disrupt a cell’s connection to its environment or, specifically, its 
basement membrane.  
 Of these pathologies are the muscular dystrophies, a group of diseases 
characterized by the progressive weakening and wasting of skeletal muscle. Clinical 
presentation of muscular dystrophy begins in early childhood and progresses through late 
adolescence, when patients often succumb to these diseases. The first recorded 
observations of muscular dystrophy were made in the mid-1800s and only in males, due 
to the X-linked recessive pattern of inheritance. This pattern requires a mutated gene on 
the X chromosome to be inherited. In females, both X chromosomes must carry the 
mutated gene in order for dystrophy to occur. In males, only the one mutated gene on the 
X chromosome (inherited from the mother) is sufficient to cause dystrophy. Because of 
this pattern, males are affected far more often than females though not all forms of 
dystrophy are X-linked recessive. When muscular dystrophy was first studied, 
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histological studies noted that the muscle cell membrane, also known as the sarcolemma, 
was disrupted or completely destroyed [1]. This is an observation researchers now know to 
be common to all forms of muscular dystrophy.  
 Types of muscular dystrophy include Duchenne, Congenital, Limb-Girdle, 
Emery-Dreifuss, Becker (a less severe form of Duchenne) and Distal muscular 
dystrophies. Genetic mutations associated with these dystrophies can include one gene, 
for example the protein dystrophin can be completely absent due to a genetic mutation. 
This change causes Duchenne muscular dystrophy; however, it is often much more 
complex than the loss of function of one gene. Frequently, dystrophies are the result of 
inadequate post-translational glycosylation of the dystroglycan protein, rather than a 
complete mutation in this protein [2]. Other dystrophies, such as congenital and Limb-
girdle muscular dystrophy, have many associated genetic mutations and these mutations 
vary greatly between affected individuals. For example, congenital muscular dystrophy 
patients often have a mutation in laminin α2, but a rare mutation can exist in the integrin 
alpha 7 protein as well [3].  
 These mutations, resulting in absent or defective proteins, cause the sarcolemma 
(the cell membrane of muscle fibers, which is normally attached to the basement 
membrane) to detach. When the sarcolemma is damaged, a muscle enzyme called 
creatine kinase seeps into the serum. Normally, creatine kinase is found in cells that use 
large amounts of adenosine triphosphate (ATP) and acts as an important buffer in the 
regeneration of ATP. Because it seeps out of damaged muscle cells, creatine kinase is 
used as a biomarker to detect muscle degeneration. Muscle cell detachment from the 
basement membrane, known as fiber detachment, is the underlying cause of muscular 
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dystrophy [2]. When fibers detach, the body regenerates the muscle cell using muscular 
stem cells called satellite cells. The constant degradation and regeneration of muscle 
tissue depletes satellite cells and the muscle wastes away [4]. Gradually, muscle is 
replaced with fatty or fibrous scar tissues.  
 In order to understand muscular dystrophy, it is imperative to first understand 
how normal muscle develops. During development, short precursor cells elongate and 
protrude from a boundary called the myotendenous junction (MTJ). These developing 
skeletal muscle cells intercalate and adhere to their respective boundaries. Finally, 
myotubules form when the elongated cells develop a uniform shape. These cells reach 
their myotome boundaries and stop extending, this is known as boundary capture [5]. 
Muscle cell boundaries form the MTJ. In this region, contractile forces are transmitted 
from the muscle to the tendon. The MTJ is rich in fibronectin and laminin, key 
components of the ECM. Muscle cells can elongate outside of their designated myotome 
and cross the MTJ. This phenomenon is known as boundary crossing and is indicative of 
dystrophy. To summarize, muscle cells become dystrophic by extending outside of their 
natural boundaries and then by becoming detached from the basement membrane. 
Detached muscle cells cannot survive and the muscle is broken down and repaired 
continuously. A similar process happens in human muscle cell development.  
 When studying muscular dystrophy, the scientific community uses several model 
organisms. In recent years, zebrafish (Danio rerio) are a more commonly used model, 
though mice models are also frequently used. Zebrafish are ideal for studying 
developmental biological processes because they develop externally from the parent and 
are transparent. Zebrafish are perfect candidates for observing muscle development 
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because fast-twitch and slow-twitch fibers are segregated. Slow-twitch muscle fibers use 
aerobic metabolism to function while fast-twitch fibers can function without oxygen and 
can carry out cellular respiration via anaerobic means. Slow-twitch muscle cells are the 
first to differentiate around sixteen hours post-fertilization (hpf). Subsequently, these 
fibers migrate laterally and the myoseptum begins to form [6]. Furthermore, zebrafish are 
an excellent model organism for studying muscular dystrophies because the genes 
dystroglycan, dystrophin and sarcoglycans show conserved sequences between humans 
and zebrafish. Finally, zebrafish develop relatively quickly, compared to other model 
organisms like mice, and their muscle can be observed in the hours and days following 
fertilization. 
Muscle cells are able to maintain contact with their basement membranes through 
specific transmembrane proteins called integrins. Integrins are crucial in signal 
transduction because they link the inside of the cell to the surrounding extracellular 
matrix (ECM). Signals regulated through integrins include both inside-out signals that 
relay information from the intracellular environment to the extracellular environment and 
outside-in signals that communicate information from the extracellular matrix into the 
cell. These integrins contain both an α and β subunit with large extracellular domains. 
Eighteen α dimers are known to exist as well as eight β dimers, creating a total twenty-
four integrin heterodimers [7]. Within the cell, integrins attach to the actin microfilaments 
making up the cytoskeleton. Integrins span the membrane of the cell and attach to ECM 
components. One of these ECM proteins is laminin, a cross-shaped molecule that attaches 
to the collagen making up the basement membrane. This relationship between laminin 
and type IV collagen is required for the formation of the basement membrane [8]. When 
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adhesion between laminin and integrin or laminin and collagen is disrupted, dystrophy 
follows.  
Muscular dystrophies occur because of mutations in a myriad of human genes. 
One of these mutations affects the integrin alpha seven (Itga7) gene. When cells adhere to 
the MTJ, fibronectin is first downregulated while laminin, Itga7, Itga6 and dystroglycan 
(Dag1) are upregulated. The Henry lab recently described the relationship among these 
genes and others in the Nrk2b pathway. Itga6 operates downstream of dag1 and Itga7 and 
is crucial for the formation of normal myogenic differentiation and myotubule formation 
[9]. Adding NAD+ can improve the overall structure of Itga7 and Itga7/dag1 morphants 
when added during development [10]. A similar logic could be applied to integrins and 
instead of using NAD+, Itga6 could potentially improve muscle structure. Because 
mutations in Itga7 and dag1 result in dystrophy in both zebrafish and humans, could 
over-expressing Itga6 rescue any embryo from dystrophy—or, rather, prevent embryos 
from developing dystrophy? This is the fundamental question of this project.  
In order to determine if over-expressing Itga6 could rescue Itga7 or dag1 
dystrophies, it is imperative to first understand these dystrophies. Itga7 morphant 
phenotypes have been extensively studied. In zebrafish, they are characterized by fiber 
detachments at around 22% of myotomes per embryo [10]. Of the integrin chains, only 
Itga6 and Itga7 are expressed during muscle development. Because Itga6 is one of the 
predominant integrins expressed during muscle development, it can potentially rescue 
Itga7 deficiencies. Itga6 is already found in these fish so there is less risk of rejection by 
the immune system.  
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Itga6 is especially prevalent in developing muscle tissue early on but expression 
then declines. In human embryonic muscle, Itga6 levels are relatively low [11]. However, 
the question is not as simple as rescuing Itga7 with Itga6. If Itga6 can effectively rescue 
Itga7 dystrophies, is it limited to rescuing only Itga7 dystrophies? The Henry lab, when 
examining NAD+ and its ability to rescue muscle, examined Itga7 and dag1 double 
morphants. Dystroglycan (dag1) morphants experience progressive muscle atrophy [12]. 
Double morphants experience fiber detachments in approximately 76% of myotomes per 
embryo [10]. In early muscle development, NAD+ supplementation rescued MTJ 
morphogenesis in double morphants by allowing appropriate adhesion to laminin [10]. 
Because Itga6 is expressed early, perhaps it can serve a similar function as NAD+ in 
Itga7/dag1 double morphants. Or, perhaps the dystrophy in the double morphants will be 
too extensive to rescue but Itga6 might sufficiently rescue the Itga7 fish.  
Rescue can be measured by counting the number of fiber detachments per embryo 
and calculating the percent found per embryo. Once this value is ascertained it can be 
compared to the previously known values. Measuring MTJ angles and comparing them to 
the known Itga7 MO angles and Itga7/dag1MO angles can also help determine if the 
Itga6 treatments effectively rescued dystrophy.   
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Materials and Methods 
Zebrafish Husbandry 
 Embryos were collected from natural spawnings of zebrafish kept on a 16-hour 
light/8-hour dark cycle. These embryos were kept at 28ºC in ERM (embryo rearing 
medium).  
Gateway and Morpholino (MO) Injections 
Injected embryos consist of six groups (see Fig. 9). The Itga6 gateway with Itga7 
MO and the Itga6 gateway with Itga7/dag MO were the two rescue groups. Injected 
alone, in order to confirm previous data, were the Itga6 gateway alone, Itga7 MO alone 
and Itga7/dag MO alone. AB fish were left uninjected as a control. One-cell embryos 
were injected at the animal pole with an Itga6 gateway β-actin GFP (green fluorescent 
protein) over-expressing construct. The injections consisted of 1.2µL of the construct, 
1µL of transposase and 2.8µL of water for a total of 5µL. The construct was stored on ice 
until it was injected. Fish were screened over the next few days for muscle fluorescence, 
indicating the over-expressing construct is effective in the developing zebrafish muscle.   
Morpholinos are antisense MO oligonucleotides engineered from Gene Tools, 
LLC. The Itga7 MO fish were injected with a 1-part Itga7 MO per 6-parts H2O dilution. 
The morpholino was injected into the yolk of the embryo. Embryos were between the one 
and four cell stage when the morpholino was injected. The Itga7/dag1 MO was made 
from 1:6 dilutions. Combining 14.7µL of H2O, 1.5µL of dag1 morpholino 1 (MO1) and 
1.8µL of dag1 morpholino 2 (MO2) resulted in a dag1 M1 concentration of 1:12 and 
dag1 M2 at 1:10. These concentrations were equal to when dag morpholinos were 
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injected alone. By combining this mixture with equal volumes of Itga7 MO the resulting 
concentration was 1:12 for Itga7, 1:24 for dag1 MO1 and 1:20 for dag1 MO2.  
AB fish were left uninjected. Fish were kept at 28ºC in an incubator for three days 
before fixing. These embryos were stored in ERM that is changed daily. Embryos were 
checked periodically and dead embryos were discarded. Embryos injected with Itga6 
gateway were screened under a microscope around 24 hours post fertilization (hpf). 
Glowing fish expressed green florescent protein where Itga6 was over-expressed. 
Embryos that glow green within the developing muscle were kept, while others were 
discarded.  
Antibody (Ab) Staining and Immunohistochemistry  
 At three days post fertilization (3 dpf), any embryos still within their chorion were 
dechorionated. This process allows the young fish to be fixed with their tails straight, 
instead of curled. Straight tails are important for clearly viewing and imaging the muscle 
structure. Embryos were fixed in 4% paraformaldehyde for four hours at room 
temperature, or overnight in the refrigerator, and then rinsed five times for five minutes 
each in Phosphate Buffered Saline-0.1% Tween20 (PBS-0.1% Tw) on a rocker. After 
this, they were permeabalized for 1.5 hours in PBS-2% Triton. Embryos were then 
incubated overnight in a 1:20 dilution of Alexa fluor 546 at 4ºC, a process called 
phalloidin staining. After phalloidin staining, embryos must be kept in the dark as much 
as possible. The tubes were covered in tin foil whenever they were not being put into 
another staining solution or rinse. 
The next day, once rinsed, the fish were put in AB block (5% w/v Bovine Serum 
Albumin in PBS-Tw) for an hour at room temperature or up to four days in the 
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refrigerator. Fixed embryos were sorted by condition into tubes, with no more than ten 
embryos per tube. To continue staining, the fish were put in polyclonal primary antibody 
overnight at 4ºC; specifically, they were stained first with the laminin-111 antibody using 
a 1:50 dilution with AB block. This antibody is distributed evenly between tubes of fish. 
The next morning, embryos were rinsed every thirty minutes with AB block at room 
temperature. Blocking after the primary antibody and before the secondary antibody is 
meant to reduce nonspecific background.  
After at least two hours of rinsing in AB block at room temperature, or up to a 
few days in the refrigerator, the secondary antibody was added. To add the secondary, 
1µL of GAR (goat anti-rabbit secondary) of the desired color is mixed with 199µL AB 
block. These embryos were already stained with phalloidin (appearing red at 543nm). 
Itga6 fibers glow green due to the GFP (at 488nm), leaving laminin to stain blue, or far 
red (at 633nm). The embryos remained the secondary antibody overnight at 4ºC. The next 
day, the embryos were washed in PBS-Tw for at least two hours and are ready to be 
deyolked.  
Deyolking and Imaging 
Embryos were deyolked in PBS using forceps. During this time, the yolk was 
removed in order to allow the embryo to lie relatively flat when mounted on a 
microscope slide. The head of the embryo was also severed underneath the eyes. Muscle 
tissue is conserved as much as possible when deyolking. Fish were then mounted in 
80%glycerol/20% PBS and ready for imaging. Images of embryos were obtained using a 
Zeiss Axio Imager Z1 microscope with a Zeiss ApoTome attachment. Embryos were 
viewed at the 10x or 20x objective. Averaging at 5 frames optimizes images.   
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Z-stack images were taken at a 1.5µm slice thickness. The red stain, representing 
the actin fibers stained with phalloidin, was crucial for showing any boundary crossings 
or fiber detachments within the myotomes. The GFP, seen as the background and within 
the myotomes, was the over-expressed green fluorescent Itga6 that was already screened 
for prior to fixing embryos. Finally, the blue stain represented laminin. Laminin was 
expected to stain particularly strongly at the MTJ because this is where the muscle fibers 
are attaching via integrins.  
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Results 
 To measure the levels of dystrophy in embryo muscle, fiber detachments were 
counted in each embryo. Operating under the assumption that all embryos have twenty-
eight myotomes each at 3dpf, the percentage of fiber detachments per embryo was 
calculated. These values were compared in the following figures (Fig. 6, 7). The 
percentages of fiber detachment were not calculated for the AB control group or the Itga6 
gateway only group. These fish, when examined, had normal tails and muscle. There is 
no reason to suspect over-expressing Itga6 would cause dystrophy. Healthy muscle 
structure in Itga6 over-expressing embryos was confirmed upon imaging.  
The Itga7 MO Rescue 
 Most embryos within the Itga7 MO rescue group showed no fiber detachments 
(Fig. 1). The actin filaments, stained red with phalloidin in figure 1A and shown in 
grayscale in Figure 1B, were attached at the MTJ. This muscle looked very similar to the 
muscle of AB (control) embryos (Fig. 8). The rescued muscle showed far fewer fiber 
detachment events than when Itga7 MO is injected alone (Fig. 5). These initial 
observations suggest the rescue may have worked. The GFP in Fig. 1 was due to the 
over-expression of Itga6 due to the gateway injections. This group of embryos stained 
uniformly and, upon inspection under the microscope, showed a green background. There 
were also muscle fibers that stained more brightly than others—a normal phenomenon 
when looking for over-expression, but not ideal. This stain confirmed that Itga6 is indeed 
over-expressed within the muscle. The few zebrafish with curved tails showed many fiber 
detachments when examined under the microscope. Imaging these embryos was difficult 
because their curved tails keep them from lying flat beneath the coverslip. Despite this, 
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Figure 2 from the same group, showed many fiber detachments in nearly every myotome 
in the image.  
Itga7 MO embryos experienced fiber detachment at approximately 22% of 
myotomes per embryo [10]. In the corresponding rescue group (Itga7 MO with Itga6 
gateway), the average amount of fiber detachment decreased to 13%, (Fig. 6). Notably, 
the standard deviation for this population was very high at ±30%. Raw data show the 
percentage of myotomes varied from 0% in ten of the embryos, while a few embryos, 
with higher percentages, brought up the average substantially. Images were taken of both 
the large proportion of embryos with few fiber detachment events (Fig. 1) as well as the 
few embryos with very curved tails and many fiber detachments (Fig. 2). Because only 
twenty-six embryos were imaged (n=26), it is not yet possible to determine statistical 
significance; however, these preliminary data are promising. The five embryos with a 
large percentage of fiber detachments were all injected on the same day so potentially this 
is due to error in methodology. It is also possible the Itga6 gateway injections are not 
completely successful in overcoming Itga7 dystrophy. Either way, the experiment must 
be repeated.  
The Itga7/dag1 MO Rescue  
 The Itga7/dag1 rescue was more difficult to measure. Though approximately 
equal numbers of embryos were injected in both rescue groups, the number of successful 
Itga7/dag1MO+Itga6 embryos dwindled either because the embryos died early on or they 
did not successfully express Itga6 in the muscle and were discarded after screening. The 
eight embryos that were imaged had relatively healthy muscle. This rescue group did not 
have a large discrepancy in the percentage of myotomes with fiber detachment like the 
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Itga7 rescue group. These embryos, at most, had fiber detachments in 7% of myotomes 
per embryo. For example, Fig. 3 showed the same embryo with two fiber detachments. 
Otherwise, the rest of the muscle fibers were attached at the MTJ. The colored image 
(Fig. 3A) showed Itga6 is over-expressed within the muscle. This image and Fig 3B, 
showing only phalloidin, when compared to the Itga7/dag1 MO alone (Fig. 4), were 
markedly healthier.  
 Itga7/Dag1 MO embryos have very unhealthy, dystrophic muscle (Fig. 4). Fiber 
detachment was around 76% of myotomes per embryo [10]. The few rescue embryos 
imaged showed an average fiber detachment of 2% with a standard deviation of ±3% 
(Fig. 7), an amount much smaller than when the morpholinos were injected alone. This is 
obviously very promising but more embryos need to be put through the experiment to 
determine significance.  
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Discussion 
 These data are very preliminary and only the beginning of answering the initial 
question: can Itga6 rescue Itga7 dystrophies? The n values for both rescue groups are too 
low to say statistically if dystrophy was rescued. There are ways the experiment could be 
tweaked, or more effectively executed, in order to better illuminate what is happening 
within the muscle. First, the Itga7 MO, when injected alone, showed some dystrophy but 
not as much as previously found in other publications [10]. There were potentially some 
consistency issues with the amount of morpholino injected. When embryos were injected, 
the amount injected into the yolk was only ascertained by looking at its size. This is not a 
perfect system and great care is needed to maintain a similar size morpholino injection 
among embryos. Even while examining the injected embryos for the appropriate size 
morpholino injection, this method is very subjective. If embryos are not injected with the 
same amount of morpholino, there will be discrepancies in the amount of dystrophy.  
 Embryos were fixed at 3dpf. The Igta7 MO embryos fixed at 3dpf looked fairly 
normal. There were a few fiber balls in most embryos but not enough to bring the 
percentage as high as 22%. Initially, this might suggest the rescue did not work because 
the fish never had dystrophy. Although this might be the case, a small number of Itga7 
MO fish were fixed at 48hpf because they looked unhealthy and were likely to die. These 
embryos had extensive dystrophy and curved tails, typical of our previously known 
phenotype for Itga7 MO. Many embryos die during the three-day wait before fixing. If all 
of the embryos with significant dystrophy died prior to three days, they were pulled out 
of the data pool and discarded. In the future, it may be best to modify the experiment and 
fix embryos at 48 hpf before the dystrophic embryos die. This should put embryos well 
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enough into muscle development to see any potential dystrophies forming but hopefully 
allow for early fixing before the fish die within the incubator. Because the 48hpf did have 
dystrophy, it is probable that the morpholino was too effective, killing the embryos 
before they could be stained and imaged.  
 Obviously, there is huge dichotomy between the Itga7MO+Itga6 gateway rescue 
phenotypes. Most of the embryos had a small percentage of fiber detachments, if any, and 
one group of embryos, all injected on the same day, had curved tails and high levels of 
fiber detachment. This could be a dosage issue with the morpholino or a problem with the 
gateway injections. The Itga6 gateway injections are tricky because they must be injected 
at the one-cell stage into the animal pole. Timing is key and if embryos develop beyond 
one-cell, they cannot effectively express Itga6 uniformly when injected. Many of the 
Itga6 gateway injected embryos died. The doubly injected rescue groups (Itga7MO+Itga6 
gateway, Itga7/dag1MO+Itga6 gateway) died even more frequently than the Itga6 
gateway injected alone. These embryos were injected twice, meaning the chorion was 
pierced twice with a needle during very early development. This puts obvious strain on 
the embryo and high mortality rates are not surprising. This is another explanation for the 
low n value. There is also the possibility for bacterial contamination. Though the media 
in which embryos develop (ERM) contains methelene blue, a dye meant to keep bacteria 
at bay, there is always the potential for contamination.  
 The Itga7/dag1MO+Itga6 gateway rescue’s n value could be low for any of the 
reasons already discussed, but it is also possible fewer embryos survived because muscle 
structure was so compromised with two morpholinos disrupting development on top of 
the strain of a second gateway injection. However, because there were eight embryos 
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with reduced fiber detachments compared to the Itga7/dag1MO alone (Fig. 4), there were 
embryos that can withstand these pressures and develop what appears to be healthy 
muscle. Repeating the experiment with many embryos (in anticipation of high mortality 
rates early on) will likely give more embryos for imaging and will also help determine if 
Itga6 can rescue both Itga7 deficiencies and dag1 deficiencies.  
 Once the embryos are about 24hpf, they are screened for glowing muscle, 
indicating the desired Itga6 over-expression. Many of these embryos do not uniformly 
express Itga6. Sometimes they do not express Itga6 at all or express it in the wrong place, 
for example within the gut of the embryo instead of in the muscle. Because these 
injections and expression are variable, injecting one hundred embryos may only yield 
twenty-five usable embryos. Again, the number of embryos injected per experiment 
should be very high to account for this. It also helps to have multiple injection 
apparatuses set up at once, so the Itga6 gateway can be injected immediately and then be 
followed by the morpholino before the cell develops beyond the one-cell stage.  
 Though these preliminary data are exciting, they only reflect the fiber detachment 
events within the rescue group embryos. This is not the only method of measuring 
dystrophy. Often, when dystrophy occurs, the somites go from V-shaped to C-shaped—
the MTJ angles increase. Determining the average MTJ angle is another way to 
conclusively say if these embryos are rescued, not only in the muscle fibers, but also at 
the MTJ itself. Another possibility for defining dystrophy is a motility assay. The muscle 
structure may look pristine, but can these embryos effectively respond to a stimulus? Can 
they swim away from the stimulus in a reasonable amount of time when compared to the 
control embryos? Can they swim at all? The motility assay is useful for determining if the 
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Itga6 rescue is successful, not just at the cellular level, but at a mechanical level sufficient 
to allow locomotion.  
 If the experiment were repeated and the results were further fleshed out to show 
Itga6 rescuing Itga7 dystrophies, the Itga6 protein would be a particularly good candidate 
for gene therapy application. Currently, gene therapy is a scientific work in progress and 
cannot cure disease—nonetheless, there are limited examples of physicians and scientists 
treating illness by over-expressing specific genes in humans. Gene therapy effectively 
reduced muscle myopathy in mouse models by over-expressing basement membrane 
components in these animals [13]. Over-expression of integrins in order to overcome 
dystrophy is a completely novel approach in muscular dystrophy gene therapy and this 
experiment has never been carried out in any context, let alone in zebrafish; however, 
other genes and their affiliated proteins are currently being considered as candidates for 
treating muscular dystrophy.  
 In order to develop gene therapies, scientists must ascertain the best potential 
protein for treating an illness, but they must also find a mechanism for sneaking these 
proteins into cells without raising an immune response. For example, patients with Itga7 
muscular dystrophies cannot receive a transfusion of Itga7 because the innate and 
acquired immune responses will cause systemic infections [14]. Muscular dystrophy 
already causes an immune response in the muscle. When muscle regenerates, the tissue is 
rich with major histocompatability complex (MHC) class I molecules [15]. These cell 
surface molecules bind to antigens and tag them for destruction. This puts dystrophic 
muscle, already saturated with MHC Class I, at a disadvantage for receiving the potential 
therapeutic benefits of gene therapy. Though the immune system would recognize and 
  18 
attack the foreign protein despite the tissue type, dystrophic muscle is even more likely to 
trigger a systemic immune response due to the ongoing myofiber necrosis [14]. A perfect 
gene therapy would introduce the effective protein into a tissue while also minimizing 
toxic effects due to immunorejection.  
Treating any disease with gene therapies is daunting because physicians are not 
expressing a gene in a one-cell embryo, as researchers might in a laboratory. Muscular 
dystrophy patients are full, complex organisms with trillions of cells. Forty percent of the 
body’s mass is made up of skeletal muscle. Researchers are challenged to deliver a 
lacking protein to all the affected cells within the body. Presently, this feat is impossible.  
A fully differentiated human cannot receive Itga6 into every cell to rescue an Itga7 
deficiency. Regardless, it may be possible to locally treat cells with a therapeutic protein 
in the attempt to alleviate symptoms of disease. Research suggests hundreds of 
intramuscular injections could be used to improve the quality of life for these patients. A 
protein could also be introduced into the vascular system and, with the help of 
vasodilators like histamine and papaverine, can make contact with the muscle fiber’s 
surface [16]. Scientists are also exploring gene transfer via stem cells by taking 
hematopoietic muscle-derived stem cells out of a patient, modifying the cells with the 
appropriate gene, using a virus, and then transplanting these cells back into the patient 
[14]. Similar methods are already being used to alleviate suffering in patients with other 
diseases.  
There is no denying the challenges of gene therapy. The Itga6 bypasses some of 
the immunorejection challenges of gene therapy by over-expressing a gene that embryos, 
and perhaps someday patients, already have and express within their cells. The Itga6 
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over-expression could capably deceive a patient’s own immune system and at the same 
time greatly improve muscle structure and function. The initial data exploring Itga6’s 
ability to rescue these dystrophies are encouraging. Much more data are needed to 
determine if Itga6 can stealthily prevent and preserve muscle from deterioration.  
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Figures and Graphs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 3dpf Itga7 MO+Itga6 gateway, 200x. 
A shows all three stains: laminin (stained blue and very faint), green fluorescent 
protein (GFP) staining over-expressed Itga6 and phalloidin staining actin filaments. B 
shows only the actin filaments stained with phalloidin. No fiber detachments are 
visible in this embryo.    
A 
B 
  21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 3dpf Itga7 MO+Itga6 gateway, 200x. 
Embryo is shown with phalloidin stain of actin filaments. There are numerous fiber detachments 
forming fiber balls, see arrows, and very wide MTJ angles. 
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Figure 3. 3dpf Itga7/dag1 MO+Itga6 gateway, 200x.  
A is stained with all three stains in the series: phalloidin, GFP and laminin-111. B 
shows only phalloidin and white arrows refer to fiber detachments.   
A 
B 
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Figure 5. 4dpf Itga7 MO[10]. 
Itga7 MO image stained with phalloidin. These embryos average fiber 
detachments in 22% of myotomes per embryo.  
Figure 4. 3dpf Itga7/dag1 MO[10]. 
Itga7/dag1 MO with many fiber detachments. These embryos 
average fiber detachments in 76% of myotomes per embryo.  
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Figure 6. Graph of average fiber detachments in Itga7 MO and rescue. 
On average, 22% of myotomes per embryo show fiber detachments[10]. Comparatively, only 
13% of myotomes per embryo show fiber detachments in the Itga7 MO + Itga6 gateway 
rescue. The error bar represents standard deviation and is missing from the left bar because this 
data set was taken from Goody, 2012.  
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Figure 7. Graph of average fiber detachments in Itga7/dag1 MO and rescue. 
On average, 76% of myotomes per embryo show fiber detachments[10] in Itga7/dag1 MO fish. 
Comparatively, only 2% of myotomes per embryo show fiber detachments in the Itga7/dag1 MO + 
Itga6 gateway rescue. The error bar represents standard deviation and is missing from the left bar 
because this data set was taken from Goody, 2012.   
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Figure 8. 3dpf AB control embryo, 200x.  
Stained with phalloidin.  
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Group Experimental Purpose 
AB (control) Observe and confirm embryos are developing 
normally 
Itga7 MO alone Look for fiber detachment levels similar to those 
found in previous experiments [10] 
Itga7 MO+Itga6 
gateway 
(rescue group) 
Determine if fiber detachment levels decreased when 
compared to the Itga7 MO alone 
Itga7/dag1 MO alone Look for fiber detachment levels similar to those 
found in previous experiments [10] 
Itga7/dag1 MO+Itga6 
gateway (rescue 
group) 
Determine if fiber detachment levels decreased when 
compared to the Itga7/dag1 MO alone 
Itga6 gateway alone Conclude the gateway injection is effective in over-
expressing Itga6 and also to determine our expected 
mortality rate regardless of morpholino injections 
 
Figure 9. Table of six injected groups of embryos and their importance in the experiment. 
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Appendix  
All procedures involving zebrafish (Danio rerio) described here are reviewed and 
approved by the IACUC at the University of Maine. 
Animal Care Certification: 
Completed on: September 4, 2009 
Certification number: 2009070 
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